CooperCompanies announced fiscal third quarter 2026 results, with revenue rising 1% year-over-year to $1.066 billion and non-GAAP diluted EPS up 4% to $1.15, while GAAP EPS surged to $2.24 on a $307.2 million tax benefit. The company completed its strategic review, repurchased $339.1 million of stock, and expanded its buyback authorization from $2 billion to $3 billion, leaving about $1.5 billion available. Free cash flow jumped 66% to $273.0 million. CooperVision revenue was flat at $717.0 million, while CooperSurgical grew 2% to $349.2 million. For fiscal 2026, the company guides total revenue of $4.229-$4.252 billion and non-GAAP EPS of $4.51-$4.55, reaffirming a long-term free cash flow objective exceeding $2.2 billion for fiscal years 2026 through 2028.
The Cooper Companies, IncQ3 revenue up 1% to $1.066B, non-GAAP EPS up 4% to $1.15, buyback expanded to $3B, and FCF jumped 66% to $273M.
